Retrospective Study
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Endosc. Oct 16, 2023; 15(10): 614-622
Published online Oct 16, 2023. doi: 10.4253/wjge.v15.i10.614
Efficacy and safety of endoscopic retrograde cholangiopancreatography in recurrent pancreatitis of pediatric asparaginase-associated pancreatitis
Kai-Hua Yang, Jing-Qing Zeng, Sheng Ding, Tian-Ao Zhang, Wen-Yu Wang, Jia-Yu Zhang, Lan Wang, Jian Xiao, Biao Gong, Zhao-Hui Deng
Kai-Hua Yang, Jing-Qing Zeng, Sheng Ding, Tian-Ao Zhang, Wen-Yu Wang, Jia-Yu Zhang, Lan Wang, Jian Xiao, Zhao-Hui Deng, Department of Gastroenterology, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China
Biao Gong, Department of Gastroenterology, Shanghai Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 200120, China
Author contributions: Yang KH, Zeng JQ, Ding S contributed equally to this work and share first authorship; Gong B and Deng ZH designed the study; Yang KH, Ding S, Zhang TA, Wang WY, Zhang JY, Wang L, Jian X acquired, analyzed, and interpreted the data; Yang KH and Zeng JQ drafted the manuscript; Deng ZH edited the manuscript; All authors contributed to the article and approved the submitted version.
Supported by the Science and Technology Commission of Shanghai Municipality of China, No. 22Y11921800.
Institutional review board statement: This study has been approved by the Institutional Ethnic Committee.
Informed consent statement: All study participants, or their legal guardian, provided written consent prior to study enrollment.
Conflict-of-interest statement: All the authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Data sharing statement: All individual data will shared. The data will be made available from the corresponding author (E-mail: dzhrj@163.com), upon reasonable request.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Zhao-Hui Deng, PhD, Chief Physician, Department of Gastroenterology, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, No. 1678 Dongfang Road, Shanghai 200127, China. dzhrj@163.com
Received: June 19, 2023
Peer-review started: June 19, 2023
First decision: August 11, 2023
Revised: August 26, 2023
Accepted: September 14, 2023
Article in press: September 14, 2023
Published online: October 16, 2023
Processing time: 114 Days and 18.1 Hours
Core Tip

Core Tip: Recurrent pancreatitis is a complication of asparaginase-associated pancreatitis (AAP), and medications do not prevent recurrence. This study was conducted to evaluate the efficacy and safety of endoscopic retrograde cholangiopancreatography (ERCP) in treating recurrent pancreatitis due to AAP. Our research found that ERCP improved clinical symptoms and reduced the incidence of pancreatitis, and was shown to be a safe and effective method for improving the management of recurrent pancreatitis due to AAP.